Retatrutide Dosing in Clinical Trials: How It's Structured

One of the most common questions about retatrutide is how it's dosed. Because retatrutide is investigational and not approved, there is no official prescribing guidance. What we do have is the dosing structure used in published clinical trials — and that's what this article summarizes.

This article describes how researchers structured doses in trials. It is not a dosing recommendation and is not medical advice. Retatrutide should only be used within a clinical trial or licensed medical setting.

Why trials use dose escalation

Like other incretin-based peptides, retatrutide can cause gastrointestinal side effects — nausea being the most common. To reduce this, trials don't start participants at a target dose. Instead they use titration: starting low and stepping up gradually over weeks so the body can adjust.

This is standard practice for the whole drug class and is the main reason dosing is described as a schedule rather than a single number.

Dose ranges studied

In the Phase 2 program, retatrutide was studied across a range of weekly subcutaneous doses, with several target-dose groups and a placebo group. Participants reached their assigned target dose through a stepwise escalation over the opening weeks of the trial.

The general pattern looked like this:

1. Initiation — a low starting dose for the first few weeks
2. Escalation — stepwise increases at set intervals
3. Maintenance — the assigned target dose for the remainder of the study

Higher target-dose groups generally showed larger average weight reductions — but also tended to report more gastrointestinal side effects, which is exactly why titration is used.

What this means if you're researching retatrutide

The key takeaways:

• There is no approved dosing — only trial protocols
• Trials use gradual escalation, not a fixed dose from day one
• Higher doses showed more effect and more side effects in studies

For the bigger picture on how retatrutide works and what trials found, see our main guide: Retatrutide: what the research actually shows.

Always consult a qualified healthcare professional before making any health decisions.